20th Canadian Melanoma Conference 2026 - Thursday, February 26, 2026

Programs and Speakers

By proceeding, you agree that OncologyEducation may anonymize any provided information, and use it for marketing research and/or promotional purposes.

Question Title

1. Occupation (please check one):

Physician (Internal Medicine)

Medical Oncologist

Radiation Oncologist

Surgeon

Surgical Oncologist

Nurse

Pharmacist

Resident / Fellow

Industry / Pharmaceutical Company

Dermatologist

Other (please specify)

Question Title

2. Please provide the authors names and titles of any CLINICAL TRIALS presented today, CMC 2026 Day 1, that you found impactful and would like more detailed information.

Question Title

3. Please rate the sessions as follows in regards to their relevance to you or how it will change your practice.

	Excellent	Very Good	Good	Fair	Poor
Regeneron Mid-Afternoon Symposium: Evolving the multi-disciplinary approach for resectable CSCC: An assessment of current and emerging approaches in the management of high risk CSCC - Dr. Teresa Petrella, Dr. Alex Mlynarek, Dr. Toni Barnes, Dr. Joel Claveau and Dr. Vanessa Bernstein	Regeneron Mid-Afternoon Symposium: Evolving the multi-disciplinary approach for resectable CSCC: An assessment of current and emerging approaches in the management of high risk CSCC - Dr. Teresa Petrella, Dr. Alex Mlynarek, Dr. Toni Barnes, Dr. Joel Claveau and Dr. Vanessa Bernstein Excellent	Regeneron Mid-Afternoon Symposium: Evolving the multi-disciplinary approach for resectable CSCC: An assessment of current and emerging approaches in the management of high risk CSCC - Dr. Teresa Petrella, Dr. Alex Mlynarek, Dr. Toni Barnes, Dr. Joel Claveau and Dr. Vanessa Bernstein Very Good	Regeneron Mid-Afternoon Symposium: Evolving the multi-disciplinary approach for resectable CSCC: An assessment of current and emerging approaches in the management of high risk CSCC - Dr. Teresa Petrella, Dr. Alex Mlynarek, Dr. Toni Barnes, Dr. Joel Claveau and Dr. Vanessa Bernstein Good	Regeneron Mid-Afternoon Symposium: Evolving the multi-disciplinary approach for resectable CSCC: An assessment of current and emerging approaches in the management of high risk CSCC - Dr. Teresa Petrella, Dr. Alex Mlynarek, Dr. Toni Barnes, Dr. Joel Claveau and Dr. Vanessa Bernstein Fair	Regeneron Mid-Afternoon Symposium: Evolving the multi-disciplinary approach for resectable CSCC: An assessment of current and emerging approaches in the management of high risk CSCC - Dr. Teresa Petrella, Dr. Alex Mlynarek, Dr. Toni Barnes, Dr. Joel Claveau and Dr. Vanessa Bernstein Poor
Artificial Intelligence for Melanoma Early Detection and Improving Health Equity - Dr. Justin Ko	Artificial Intelligence for Melanoma Early Detection and Improving Health Equity - Dr. Justin Ko Excellent	Artificial Intelligence for Melanoma Early Detection and Improving Health Equity - Dr. Justin Ko Very Good	Artificial Intelligence for Melanoma Early Detection and Improving Health Equity - Dr. Justin Ko Good	Artificial Intelligence for Melanoma Early Detection and Improving Health Equity - Dr. Justin Ko Fair	Artificial Intelligence for Melanoma Early Detection and Improving Health Equity - Dr. Justin Ko Poor
Microbiome and FMT in Melanoma - Dr. Arielle Elkrief	Microbiome and FMT in Melanoma - Dr. Arielle Elkrief Excellent	Microbiome and FMT in Melanoma - Dr. Arielle Elkrief Very Good	Microbiome and FMT in Melanoma - Dr. Arielle Elkrief Good	Microbiome and FMT in Melanoma - Dr. Arielle Elkrief Fair	Microbiome and FMT in Melanoma - Dr. Arielle Elkrief Poor
Imaging & Resistance - Dr. Ian Watson	Imaging & Resistance - Dr. Ian Watson Excellent	Imaging & Resistance - Dr. Ian Watson Very Good	Imaging & Resistance - Dr. Ian Watson Good	Imaging & Resistance - Dr. Ian Watson Fair	Imaging & Resistance - Dr. Ian Watson Poor
Legacy Award 2026 Introduction - Dr. Clair Temple-Oberle, Dr. Noelle Davis, Dr. Scott Ernst	Legacy Award 2026 Introduction - Dr. Clair Temple-Oberle, Dr. Noelle Davis, Dr. Scott Ernst Excellent	Legacy Award 2026 Introduction - Dr. Clair Temple-Oberle, Dr. Noelle Davis, Dr. Scott Ernst Very Good	Legacy Award 2026 Introduction - Dr. Clair Temple-Oberle, Dr. Noelle Davis, Dr. Scott Ernst Good	Legacy Award 2026 Introduction - Dr. Clair Temple-Oberle, Dr. Noelle Davis, Dr. Scott Ernst Fair	Legacy Award 2026 Introduction - Dr. Clair Temple-Oberle, Dr. Noelle Davis, Dr. Scott Ernst Poor
Legacy Award 2026 Recipient Presentation - Dr. Greg McKinnon	Legacy Award 2026 Recipient Presentation - Dr. Greg McKinnon Excellent	Legacy Award 2026 Recipient Presentation - Dr. Greg McKinnon Very Good	Legacy Award 2026 Recipient Presentation - Dr. Greg McKinnon Good	Legacy Award 2026 Recipient Presentation - Dr. Greg McKinnon Fair	Legacy Award 2026 Recipient Presentation - Dr. Greg McKinnon Poor

Question Title

* 1. Occupation (please check one):

Question Title

* 2. Please provide the authors names and titles of any CLINICAL TRIALS presented today, CMC 2026 Day 1, that you found impactful and would like more detailed information.

Question Title

* 3. Please rate the sessions as follows in regards to their relevance to you or how it will change your practice.

1. Occupation (please check one):

2. Please provide the authors names and titles of any CLINICAL TRIALS presented today, CMC 2026 Day 1, that you found impactful and would like more detailed information.

3. Please rate the sessions as follows in regards to their relevance to you or how it will change your practice.